These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36939895)

  • 1. Glycemic control predicts SARS-CoV-2 prognosis in diabetic subjects.
    Greco C; Pirotti T; Brigante G; Filippini T; Pacchioni C; Trenti T; Simoni M; Santi D
    Acta Diabetol; 2023 Jun; 60(6):817-825. PubMed ID: 36939895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preserved seasonal variation in glycemic control in patients with type 2 diabetes mellitus during COVID-19: a 3-year-long retrospective cohort study in older adults in Japan.
    Iwata S; Ashida K; Demiya M; Nagayama A; Hasuzawa N; Yoshinobu S; Sonezaki A; Yasuda J; Motomura S; Katsuki Y; Sugi K; Nomura M
    BMC Endocr Disord; 2024 May; 24(1):70. PubMed ID: 38755559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with prediabetes are at greater risk of developing diabetes 5 months postacute SARS-CoV-2 infection: a retrospective cohort study.
    Xu AY; Wang SH; Duong TQ
    BMJ Open Diabetes Res Care; 2023 Jun; 11(3):. PubMed ID: 37295808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of SARS-CoV-2 Infection and Infection Severity on Longer-Term Glycemic Control and Weight in People With Type 2 Diabetes.
    Wong R; Vaddavalli R; Hall MA; Patel MV; Bramante CT; Casarighi E; Johnson SG; Lingam V; Miller JD; Reusch J; Saltz M; Stürmer T; Tronieri JS; Wilkins KJ; Buse JB; Saltz J; Huling JD; Moffitt R;
    Diabetes Care; 2022 Nov; 45(11):2709-2717. PubMed ID: 36098660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telemedicine and urban diabetes during COVID-19 pandemic in Milano, Italy during lock-down: epidemiological and sociodemographic picture.
    Luzi L; Carruba M; Crialesi R; Da Empoli S; Dagani R; Lovati E; Nicolucci A; Berra CC; Cipponeri E; Vaccaro K; Lenzi A
    Acta Diabetol; 2021 Jul; 58(7):919-927. PubMed ID: 33740123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and predictors of suboptimal glycemic control among patients with type 2 diabetes mellitus in northern Thailand: A hospital-based cross-sectional control study.
    Yeemard F; Srichan P; Apidechkul T; Luerueang N; Tamornpark R; Utsaha S
    PLoS One; 2022; 17(1):e0262714. PubMed ID: 35041704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycemic Control and Mucormycosis during COVID-19 Pandemic in India a Study of Stage and Outcome.
    Sharma V; Kriplani K; Tuli IP; Sharma S; Narula A
    J Assoc Physicians India; 2023 Sep; 71(9):61-66. PubMed ID: 38700303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptoms and Glycemic Control in Young People With Type 1 Diabetes Following SARS-CoV-2 Infection: An Observational Study.
    Nimri R; Rachmiel M; Yackobovitch-Gavan M; Brener A; de Vries L; Fisch Shvalb N; Lazar L; Oren A; Jacobi-Polishook T; Shefer Averbuch N; Tenenbaum A; Mel E; Krepel Volsky S; Mouler M; Demol S; Shalitin S; Bello R; Phillip M; Lebenthal Y
    J Clin Endocrinol Metab; 2022 Jul; 107(8):e3264-e3272. PubMed ID: 35524727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic control and the risk of tuberculosis in patients with diabetes: A cohort study in a Mediterranean city.
    Antonio-Arques V; Caylà JA; Real J; Moreno-Martinez A; Orcau À; Mauricio D; Mata-Cases M; Julve J; Navas Mendez E; Puig Treserra R; Millet JP; Del Val García JL; Vlacho B; Franch-Nadal J
    Front Public Health; 2022; 10():1017024. PubMed ID: 36466495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with critical care requirements in diabetic patients treated with dexamethasone for COVID-19 infection in the first wave of the pandemia.
    Batule S; Soldevila B; Figueredo C; Julián MT; Egea-Cortés L; Reyes-Ureña J; Casabona J; Mateu L; Paredes R; Clotet B; López R; Puig-Domingo M; Alonso N
    Front Endocrinol (Lausanne); 2022; 13():1009028. PubMed ID: 36619546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily.
    Silverii GA; Monami M; Cernigliaro A; Vigneri E; Guarnotta V; Scondotto S; Allotta VA; Conti M; Giordano C; Mannucci E
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):396-398. PubMed ID: 33223405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Year-Long Trend in Glycated Hemoglobin Levels in Patients with Type 2 Diabetes during the COVID-19 Pandemic.
    Jin J; Lee SW; Lee WK; Jeon JH; Kim JG; Lee IK; Choi YK; Park KG
    Endocrinol Metab (Seoul); 2021 Oct; 36(5):1142-1146. PubMed ID: 34674507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Comorbid Diabetes on Clinical Characteristics of COVID-19 Patients Infected by the Wild-Type or Delta Variant of SARS-CoV-2.
    Zhang J; Zhang J; Tao Z
    Front Endocrinol (Lausanne); 2022; 13():861443. PubMed ID: 35600601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of diabetes and the prognosis of COVID-19 patients: A retrospective study.
    Liu Z; Bai X; Han X; Jiang W; Qiu L; Chen S; Yu X
    Diabetes Res Clin Pract; 2020 Nov; 169():108386. PubMed ID: 32853685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 1 diabetes mellitus and SARS-CoV-2 in pediatric and adult patients - Data from the DPV network.
    Büttner BR; Tittel SR; Kamrath C; Karges B; Köstner K; Melmer A; Müller-Roßberg E; Richter F; Rohrer TR; Holl RW
    J Diabetes; 2022 Nov; 14(11):758-766. PubMed ID: 36443963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2.
    Elamari S; Motaib I; Zbiri S; Elaidaoui K; Chadli A; Elkettani C
    Pan Afr Med J; 2020; 37():32. PubMed ID: 33209159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycated hemoglobin level dynamics in COVID-19 survivors: 12 months follow-up study after discharge from hospital.
    Shestakova M; Kononenko I; Kalmykovа Z; Markova T; Kaplun E; Lysenko M; Mokrysheva N
    PLoS One; 2022; 17(11):e0275381. PubMed ID: 36350895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of urgently initiated tele-prescription due to COVID-19 on glycemic control in patients with type 2 diabetes.
    Park SD; Kim NY; Jeon JH; Kim JG; Lee IK; Park KG; Choi YK
    Korean J Intern Med; 2021 Jul; 36(4):942-948. PubMed ID: 34092049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A UK nationwide study of people with type 1 diabetes admitted to hospital with COVID-19 infection.
    Ruan Y; Ryder REJ; De P; Field BCT; Narendran P; Iqbal A; Gandhi R; Harris S; Nagi D; Aziz U; Karra E; Ghosh S; Hanif W; Edwards AE; Zafar M; Dashora U; Várnai KA; Davies J; Wild SH; Wilmot EG; Webb D; Khunti K; Rea R;
    Diabetologia; 2021 Aug; 64(8):1717-1724. PubMed ID: 33966090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of diabetes mellitus on disease prognosis in COVID-19 patients.
    Altin Z; Yasar HY
    Ir J Med Sci; 2022 Dec; 191(6):2619-2624. PubMed ID: 35411486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.